News Item Archive
[First/Prev] 1, 2, 3, 4, 5, 6, 7, 8 [Next/Last]| Posted Date | Description |
|---|---|
| 11/27/2011 | From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource. |
| 11/01/2011 | CYP2C19 VIP in Pharmacogenetics and Genomics |
| 10/18/2011 | CYP1A2 VIP in Pharmacogenetics and Genomics |
| 07/11/2011 | Carbamazepine Pathway in Pharmacogenetics and Genomics |
| 06/16/2011 | Caffeine Pathway |
| 06/16/2011 | Lamivudine Pathway |
| 06/16/2011 | Zidovudine Pathway |
| 05/09/2011 | Citalopram Pathway in Pharmacogenetics and Genomics |
| 04/08/2011 | Very Important Pharmacogene Information for CYP1A2 |
| 02/15/2011 | Methotrexate Pathway in Pharmacogenetics and Genomics |
PharmGKB® is a registered trademark of HHS and is
financially supported by NIH/NIGMS.
It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.
©2001-2012 PharmGKB.